4//SEC Filing
Tursi James Patrick 4
Accession 0001209191-19-037223
CIK 0001016169other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:34 PM ET
Size
7.7 KB
Accession
0001209191-19-037223
Insider Transaction Report
Form 4
Tursi James Patrick
EVP, Chief Medical Officer
Transactions
- Award
Common Stock
2019-06-13$2.92/sh+45,205$131,999→ 45,205 total - Award
Stock Option (right to buy)
2019-06-13+90,788→ 90,788 totalExercise: $2.92Exp: 2029-06-13→ Common Stock (90,788 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F3]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001527710
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:34 PM ET
- Size
- 7.7 KB